Filing Flows › Zymeworks (ZYME) › Q1 2026 › vs Q1 2025
Zymeworks (ZYME) Q1 2026 vs Q1 2025 (year over year)
Zymeworks's revenue fell $24.7M (-91%) from $27.1M in Q1 2025 to $2.4M in Q1 2026.
Zymeworks, Q1 2026: revenue $2.4M (-91% year over year), net loss $44.2M, operating cash flow −$45.7M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.4M | $27.1M | −$24.7M | -91% |
| Other income, net | $765K | $3.5M | −$2.7M | -78% |
| Income tax benefit | $2.2M | −$496K | $2.7M | — |
| Net loss | $44.2M | $22.6M | $21.5M | +95% |
| Costs & expenses | $49.5M | $53.2M | −$3.7M | -7% |
| Operating costs | $49.5M | $52.7M | −$3.2M | -6% |
| Research & development | $34.5M | $35.7M | −$1.3M | -4% |
| General & admin | $15.1M | $17.0M | −$1.9M | -11% |
| Operating cash sources | $53.8M | $12.4M | $41.4M | +334% |
| Depreciation & amortization | $1.1M | $2.6M | −$1.5M | -56% |
| Share-based compensation | $6.9M | $6.4M | $533K | +8% |
| Cash used in operations | $45.7M | $3.4M | $42.3M | 13× |
| Net loss absorbed | $44.2M | $22.6M | $21.5M | +95% |
| Working capital & other | $9.6M | −$10.2M | $19.9M | — |
Questions
How much did Zymeworks's revenue grow year over year in Q1 2026?
Zymeworks's revenue fell $24.7M (-91%) from $27.1M in Q1 2025 to $2.4M in Q1 2026.